Sumitomo Dainippon Oncology Announces First Patient Dosed in the Dubermatinib
23 Oct 2020 //
PRNEWSWIRE
SumitomoDainipponPharma Oncology Presents PhI Study Evaluating Dubermatinib:ESMO
18 Sep 2020 //
BIOSPACE
23 Oct 2020 //
PRNEWSWIRE
18 Sep 2020 //
BIOSPACE